Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-04 | New | $7,000,000 | Unknown | Equity Only | SEC link | |
| 2021-09-01 | New | $70,000,000 | $70,000,000 | Equity Only | 06b | SEC link |
| 2016-01-19 | New | $1,020,000 | $1,020,000 | Equity Only | 06b | SEC link |
| 2013-12-27 | New | $1,136,000 | $1,136,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael M. Abecassis | Director |
| Robert Bowker | Director |
| Gerald W Crabtree | Director, Executive |
| Crabtree W. Crabtree | Director, Executive |
| Richard M. Goldfarb | Director |
| Patricia Gruden | Executive |
| Thomas Liquard | Director |
| Timothy Matula | Director |
| Robert F. Ryan | Director |
| Jonathan L. Schechter | Director |
| Joshua N. Silverman | Director, Executive |
| Raymond Cf Tong | Director |
| Carlos Trujillo | Executive |
| Kenneth L. Waggoner | Director, Executive |
| Walker R. Wayne | Director |
| Robert Weinstein | Director |
| Thomas C.K. Yuen | Director |